The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs).
M. A. Pantaleo
No relevant relationships to disclose
A. Astolfi
No relevant relationships to disclose
V. Indio
No relevant relationships to disclose
P. Paterini
No relevant relationships to disclose
S. Formica
No relevant relationships to disclose
R. Casadio
No relevant relationships to disclose
P. Martelli
No relevant relationships to disclose
A. Maleddu
No relevant relationships to disclose
M. Nannini
No relevant relationships to disclose
A. P. Dei Tos
No relevant relationships to disclose
M. C. Heinrich
Consultant or Advisory Role - Novartis
D. Santini
No relevant relationships to disclose
F. Catena
No relevant relationships to disclose
C. Ceccarelli
No relevant relationships to disclose
M. Fiorentino
No relevant relationships to disclose
M. di Battista
No relevant relationships to disclose
R. Moore
No relevant relationships to disclose
N. Thiessen
No relevant relationships to disclose
C. Gnocchi
Employment or Leadership Position - Novartis
G. Biasco
No relevant relationships to disclose